Bupropion Hydrochloride SR
NDC 71335-1837, bupropion hydrochloride, tablet, extended release, from Bryant Ranch Prepack.
- Product NDC
- 71335-1837
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211347
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1837 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPROPION HYDROCHLORIDE150 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71335-1837-1 | 71335183701 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-1) |
| 71335-1837-2 | 71335183702 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-2) |
| 71335-1837-3 | 71335183703 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-3) |
| 71335-1837-4 | 71335183704 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-4) |
| 71335-1837-5 | 71335183705 | 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-5) |
| 71335-1837-6 | 71335183706 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-6) |
| 71335-1837-7 | 71335183707 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-7) |
| 71335-1837-8 | 71335183708 | 56 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-8) |
| 71335-1837-9 | 71335183709 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-9) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0574b84d-075f-410f-a8eb-86901e307ea2
Use it
Look up 71335-1837 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1837 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71335-1837. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.